ILOZOLE SB 65 CAPSULEA

Product Description

ILOZOLE SB 65 CAPSULES contain Itraconazole 65 mg, a powerful broad-spectrum antifungal agent widely used for treating systemic and superficial fungal infections. Known for its strong tissue penetration and sustained antifungal activity, ILOZOLE SB 65 is highly effective in managing dermatophytosis, onychomycosis, oral thrush, and systemic mycoses.

Manufactured in WHO-GMP certified facilities, this formulation is ideal for prescription use in dermatology, internal medicine, and infectious disease practices. Designed for high bioavailability and patient compliance, ILOZOLE SB 65 is in high demand across pharmaceutical wholesalers, hospital pharmacies, and retail chains.

Key Benefits:

• Contains Itraconazole 65 mg proven efficacy against fungal infections

• Ideal for treating skin, nail, and mucosal fungal conditions

• Excellent bioavailability with fewer GI side effects

• Suitable for short and long-term antifungal therapy

Applications:

• Treatment of tinea corporis, tinea cruris, and tinea pedis

• Effective in vaginal candidiasis, oral candidiasis, and fungal nail infections

• Prescribed for systemic fungal infections in immunocompromised patients

Why Choose ILOZOLE SB 65 CAPSULES?

• High-demand antifungal product in clinical and retail segments

• Attractive margins for distributors and bulk buyers

• Ready for B2B orders, third-party manufacturing, and PCD franchise opportunities